These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 26831924

  • 21. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT, Khorooshi R, Owens T.
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [Abstract] [Full Text] [Related]

  • 22. α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
    Ettle B, Kuhbandner K, Jörg S, Hoffmann A, Winkler J, Linker RA.
    J Neuroinflammation; 2016 Aug 26; 13(1):201. PubMed ID: 27565429
    [Abstract] [Full Text] [Related]

  • 23. Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.
    Massilamany C, Gangaplara A, Kim H, Stanford C, Rathnaiah G, Steffen D, Lee J, Reddy J.
    J Neuroimmunol; 2013 Mar 15; 256(1-2):19-27. PubMed ID: 23294897
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D, Lu Z, Zhang H, Jin SF, Yang H, Li YM, Shi LY.
    CNS Neurosci Ther; 2016 Jul 15; 22(7):558-67. PubMed ID: 27013083
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis.
    Moriguchi K, Miyamoto K, Tanaka N, Ueno R, Nakayama T, Yoshie O, Kusunoki S.
    J Neuroimmunol; 2016 Feb 15; 291():54-8. PubMed ID: 26857495
    [Abstract] [Full Text] [Related]

  • 29. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA, Wong G, Tenorio G, Baker GB, Kerr BJ.
    Behav Brain Res; 2013 Sep 01; 252():302-11. PubMed ID: 23777648
    [Abstract] [Full Text] [Related]

  • 30. Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
    Yin JX, Tang Z, Gan Y, Li L, Shi F, Coons S, Shi J.
    Neuropharmacology; 2014 Jun 01; 81():1-5. PubMed ID: 24486709
    [Abstract] [Full Text] [Related]

  • 31. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y, Inaba Y, Matsuda K, Itoh M, Kaneyama T, Nakazawa Y, Koh CS, Ichikawa M.
    J Neurol Sci; 2014 May 15; 340(1-2):117-22. PubMed ID: 24655735
    [Abstract] [Full Text] [Related]

  • 32. Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis.
    Fitzgerald DC, O'Brien K, Young A, Fonseca-Kelly Z, Rostami A, Gran B.
    J Neuroinflammation; 2014 Jul 28; 11():130. PubMed ID: 25069698
    [Abstract] [Full Text] [Related]

  • 33. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
    Peng Z, Zhang L, Wang H, He X, Peng X, Zhang Q, Liu H, Rao J, Wang H, Wu J, Sun Y.
    Protein Pept Lett; 2018 Feb 08; 24(12):1166-1178. PubMed ID: 29141529
    [Abstract] [Full Text] [Related]

  • 34. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
    Breuer J, Korpos E, Hannocks MJ, Schneider-Hohendorf T, Song J, Zondler L, Herich S, Flanagan K, Korn T, Zarbock A, Kuhlmann T, Sorokin L, Wiendl H, Schwab N.
    J Neuroinflammation; 2018 Aug 22; 15(1):236. PubMed ID: 30134924
    [Abstract] [Full Text] [Related]

  • 35. Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE.
    Esen N, Katyshev V, Serkin Z, Katysheva S, Dore-Duffy P.
    J Neuroinflammation; 2016 Jan 19; 13():13. PubMed ID: 26785841
    [Abstract] [Full Text] [Related]

  • 36. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, Vollmer TL.
    Exp Neurol; 2010 Jan 19; 221(1):136-45. PubMed ID: 19879259
    [Abstract] [Full Text] [Related]

  • 37. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
    Xu J, Wagoner G, Douglas JC, Drew PD.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):46-54. PubMed ID: 23010281
    [Abstract] [Full Text] [Related]

  • 38. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    Vaitaitis GM, Yussman MG, Waid DM, Wagner DH.
    PLoS One; 2017 Jan 15; 12(2):e0172037. PubMed ID: 28192476
    [Abstract] [Full Text] [Related]

  • 39. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
    Thomé R, de Carvalho AC, Alves da Costa T, Ishikawa LL, Fraga-Silva TF, Sartori A, de Oliveira AL, Verinaud L.
    CNS Neurosci Ther; 2016 Aug 15; 22(8):707-14. PubMed ID: 27165523
    [Abstract] [Full Text] [Related]

  • 40. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C, Ciric B, Yu S, Zhang GX, Rostami A.
    J Neuroimmunol; 2016 Feb 15; 291():59-69. PubMed ID: 26857496
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.